Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Targeting the skin's endocannabinoid system could help treat skin disorders.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Mushrooms have beneficial properties for skin and hair care products and have great potential for future cosmetic use.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Minoxidil and finasteride treat hair loss; more research needed for other options.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

S100A4 and S100A6 proteins may activate stem cells for hair follicle regeneration and could be potential targets for hair loss treatments.

The p53 protein helps control hair follicle shrinking by promoting cell death in mice.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Vitamin D3 affects cell differentiation in specific skin areas.

Advanced human skin models improve drug development and could replace animal testing.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

Noggin overexpression delays eyelid opening by affecting cell death and skin cell development.

Blocking BMP signaling causes hair loss and disrupts hair growth cycles.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Certain signals and genes play a key role in hair growth and regeneration, and understanding these could lead to new treatments for skin regeneration.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

The document concludes that electrolysis and thermolysis can permanently remove hair but calls for better regulation to ensure safety, and notes a possibility of hair regrowth and rare complications.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.